Pulmonary fibrosis and interstitial lung disease (ILD) following COVID-19 (336–338) may be due to an initial hyperproliferation of pathologic fibroblasts acting via TGF-β signaling (339). The gene discussed is TGFB1; the disease is COVID-19.